US Patent 8399514 Treatment for multiple sclerosis
Patent 8399514 was granted and assigned to Biogen on March, 2013 by the United States Patent and Trademark Office.
Is a
Current Assignee
Date Filed
February 13, 2012
Date of Patent
March 19, 2013
Patent Application Number
13372426
Patent Citations Received
Patent Jurisdiction
Patent Number
Patent Primary Examiner
Find more entities like US Patent 8399514 Treatment for multiple sclerosis
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
